# SYSTEMATIC SYMPTOM ASSESSMENT IN CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS

> **NCT04929353** · NA · UNKNOWN · sponsor: **University Of Perugia** · enrollment: 280 (estimated)

## Conditions studied

- Melanoma
- Lung Cancer

## Interventions

- **OTHER:** Systematic symptom assessment

## Key facts

- **NCT ID:** NCT04929353
- **Lead sponsor:** University Of Perugia
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-20
- **Primary completion:** 2023-06-20
- **Final completion:** 2024-06-20
- **Target enrollment:** 280 (ESTIMATED)
- **Last updated:** 2021-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04929353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04929353, "SYSTEMATIC SYMPTOM ASSESSMENT IN CANCER PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04929353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*